Novavax (NVAX) Intangibles (2013 - 2022)
Novavax (NVAX) posted quarterly Intangibles of $8.5 million for Q3 2022, up 68.21% year-over-year from $5.0 million in Q3 2021, and up 109.67% quarter-over-quarter from $4.0 million in Q2 2022.
Novavax (NVAX) Intangibles (2013 - 2022) Analysis & Trends
Novavax's Intangibles history runs 10 years deep, the most recent figure standing at $8.5 million for Q3 2022.
- In Q3 2022, Intangibles rose 68.21% year-over-year to $8.5 million; the TTM figure through Sep 2022 stood at $8.5 million (up 68.21% YoY), while the FY2021 annual figure was $4.8 million, down 16.68% from the prior year.
- Intangibles for Q3 2022 stood at $8.5 million, up from $4.0 million in the prior quarter.
- The five-year high for Intangibles was $8.5 million in Q3 2022, with the low at $4.0 million in Q2 2022.
- The 5-year median for Intangibles is $5.5 million (2019), against an average of $5.8 million.
- The sharpest annual moves came in 2018 and 2022: Intangibles fell 27.21% in 2018, then jumped 68.21% in 2022.
- Novavax's Intangibles stood at $6.5 million in 2018, then dropped by 14.68% to $5.6 million in 2019, then increased by 2.58% to $5.7 million in 2020, then slipped by 16.68% to $4.8 million in 2021, then soared by 77.27% to $8.5 million in 2022.
- Business Quant data shows NVAX's Intangibles at $8.5 million in Q3 2022, $4.0 million in Q2 2022, and $4.5 million in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Novavax | 1.33 Bn | 607.37 Mn | 42.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 8.46 Mn |
| Jun 30, 2022 | 4.03 Mn |
| Mar 31, 2022 | 4.54 Mn |
| Dec 31, 2021 | 4.77 Mn |
| Sep 30, 2021 | 5.03 Mn |
| Jun 30, 2021 | 5.28 Mn |
| Mar 31, 2021 | 5.27 Mn |
| Dec 31, 2020 | 5.73 Mn |
| Sep 30, 2020 | 5.33 Mn |
| Jun 30, 2020 | 5.25 Mn |
| Mar 31, 2020 | 5.05 Mn |
| Dec 31, 2019 | 5.58 Mn |
| Sep 30, 2019 | 5.47 Mn |
| Jun 30, 2019 | 5.96 Mn |
| Mar 31, 2019 | 6.11 Mn |
| Dec 31, 2018 | 6.54 Mn |
| Sep 30, 2018 | 6.75 Mn |
| Jun 30, 2018 | 6.90 Mn |
| Mar 31, 2018 | 7.58 Mn |
| Dec 31, 2017 | 7.87 Mn |